Repligen Corporation is a bioprocessing company that plays a pivotal role in the biotechnology and pharmaceutical industries. Its primary function revolves around the development and supply of bioproc... Repligen Corporation is a bioprocessing company that plays a pivotal role in the biotechnology and pharmaceutical industries. Its primary function revolves around the development and supply of bioprocessing technologies, essential for the production of biologics. The company offers a wide array of products, including protein A ligands, chromatography resins, and filtration technologies designed to enhance the efficiency and scalability of biologic drug manufacturing processes. Repligen's cutting-edge solutions cater to a variety of applications, including antibody production, gene therapy, and cell therapy, addressing the growing demand for biopharmaceuticals. Headquartered in Waltham, Massachusetts, Repligen Corporation has gained significant market recognition for its innovative contributions to bioprocessing, facilitating advancements in therapeutic manufacturing and delivery. Its impact is especially pronounced as the biopharmaceutical sector continues expanding, driven by the increasing need for targeted therapies and personalized medicine.
Pending data availability
EU Taxonomy Data missing for Repligen
We haven’t collected EU Taxonomy data for Repligen yet, or the company
hasn’t made it publicly available.